What investor type does GSK fit best in FoxScore?

GSK fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.

How meaningful is the available history for GSK?

GSK currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for GSK

GSK.UK · As of: 02/17/2026

Basic information

Type: Stock

Region: UK

Sector: Health Care

TER: –

History

Available history:15.0 years

Last tradingday:02/17/2026

Description & usage

GSK is a pharmaceutical company that researches, develops, manufactures and supplies prescription medicines and vaccines. It earns revenue by selling these products to healthcare systems, hospitals, pharmacies and governments, using different procurement and reimbursement models across countries. The customer base is global, with vaccines programs and selected specialty therapies playing an important role. R&D and clinical development are core to the model, supporting new launches and expanded uses of existing products.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

GSK (GSK.UK) currently has a total score of 65 points, placing it in the strong range. The score is made up of Performance (51), Stability (74) and Trend (87). The profile is clearly uneven: Trend stands out while Performance is more neutral.

Performance scores 51 points (neutral). Key strength: 1Y return at 54.3 %. Weaker metric: 10Y return at 57.1 %. This points to a sharper upswing more recently.

Stability scores 74 points (strong). Key strength: Sortino ratio (90d) at 7.07. Main drag: CAGR/drawdown ratio at 0.13. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 87 points (very strong). Key strength: Price is about 17.2 % above SMA50. Even the weakest metric remains solid in absolute terms: trend strength at 0.82. That often means the move is strong, but not perfectly steady.

Overall, the profile has a clear strength in Trend, while Performance is the main limiter. On a metric level, Sortino ratio (90d) stands out, while 10Y return lags.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

strong

Scores

Metrics

FAQ

What investor type does GSK fit best in FoxScore?: GSK fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
How meaningful is the available history for GSK?: GSK currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.